Clinical Trial: Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability, of Ertapenem Versus Piperacillin/Tazobactam in the Tr
Brief Summary: This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus another intravenous antibiotic in the treatment of moderate to severe diabetic foot infections.
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Clinical Cure/Improvement at discontinuation of IV antibiotic therapy.
Original Primary Outcome: Same as current
Current Secondary Outcome: Clinical Cure: 1. Day 5 of IV antibiotic therapy; 2.10 days after completion of all antibiotic therapy.
Original Secondary Outcome: Same as current
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: September 27, 2005
Date Started: April 2001
Date Completion:
Last Updated: February 16, 2017
Last Verified: February 2017